Medical Data Vision accepts a takeover bid from Nippon Life, aiming to enhance health data analytics services and fortify its market position.
Target Company Overview
Medical Data Vision Co., Ltd. (MDV) specializes in providing diagnostic data analysis tools and databases aimed at healthcare institutions. The company was founded in 2003 and has grown significantly since its initial public offering on the Tokyo Stock Exchange Mother's market in 2014, later transitioning to the First Section in 2016, and recently to the Prime Market in April 2022. The firm has established a strong reputation for its innovative healthcare solutions.
On December 15, 2025, MDV has accepted a takeover bid (TOB) from Nippon Life Insurance Company, a major player in the insurance industry. This acquisition is part of Nippon Life's strategy to strengthen its foothold in health data analysis, thereby enhancing its offerings in both healthcare and insurance sectors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The Japanese insurance market has faced significant challenges recently due to institutional reforms and the entry of non-traditional players, which have negatively impacted the competi
Similar Deals
Carlyle Group → HOGY Medical
2025
Omron Healthcare → Matsuya R&D
2025
Advantage Partners (AP) and LYFE Capital Investment Management Ltd. → Nihon Chouzai Co., Ltd.
2025
Tokyo University Co-Creation Platform Development Co., Ltd. → Heartseed Inc.
2024
San Holdings → Kizuna Holdings
2023
日本生命保険
invested in
メディカル・データ・ビジョン
in 2025
in a Public-to-Private (P2P) deal
Disclosed details
Transaction Size: $576M